By Administrator_India Capital Sands India’s drug regulator on Sunday gave its final approval to the Oxford-AstraZeneca and Bharat Biotech coronavirus vaccines for restricted use in an emergency situation, giving the country its first two shots for immunising its vast population in the coming weeks. While the Oxford-AstraZeneca vaccine, manufactured by Serum Institute of India (SII), has 70.42 per cent efficacy, the indigenous […]
Read MoreBy Administrator_India Capital Sands Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded. The UK has had more than 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 […]
Read MoreBy Administrator_India Capital Sands Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects. Whether any of these efforts will result in a vaccine capable […]
Read More